Technology News and Research

RSS

EU initiative develops advanced diagnostics with light and AI

Led by the UPC's Centre for Sensors, Instruments and Systems Development, an international consortium of universities, hospitals and companies is developing new technologies based on light and AI to improve the diagnosis of several diseases.

25 Jan 2024

Groundbreaking joint statement issued on the development and use of AI tools in radiology

The American College of Radiology, working in close collaboration with four other radiology societies from around the world, have issued a joint statement on the development and use of artificial intelligence (AI) tools in radiology.

25 Jan 2024

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

From Bio-Techne 25 Jan 2024

Study shows effectiveness of gene therapy in treating congenital deafness

A new study co-led by investigators from Mass Eye and Ear, a member of Mass General Brigham, demonstrated the effectiveness of a gene therapy towards restoring hearing function for children suffering from hereditary deafness.

24 Jan 2024

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Researchers analyzed the toxicity concerns and advancements in mRNA therapeutics, focusing on their cellular toxicity, reactogenicity, and distribution, and discussed the challenges and benefits of mRNA research.

24 Jan 2024

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine, researchers from the Perelman School of Medicine at the University of Pennsylvania reported today in Nature Medicine.

24 Jan 2024

New study reveals key tissues involved in HIV rebound after treatment

In findings that have implications for potential new HIV therapies, researchers from Texas Biomedical Research Institute (Texas Biomed) used genetic sequencing techniques on the nonhuman primate version of the virus to identify that lymph nodes in the abdomen are the leading source of rebound infection after the first week of stopping antiretroviral treatment.

24 Jan 2024

New drug combination could reduce malaria infection risk in pregnant women living with HIV

Researchers have tested a new combination of medications that could thwart resistance to common malaria drugs, significantly reducing the infection risk in pregnant women living with HIV.

24 Jan 2024

Groundbreaking technology shows immense potential for treating ischemic retinopathy

A groundbreaking technology with immense potential in treating ischemic retinopathy in premature infants and diabetic patients has been developed by Professor Byoung Heon Kang and his research team in the Department of Biological Sciences at UNIST, in collaboration with Professor Dong Ho Park's team at Kyungpook National University Hospital. Ischemic retinopathy, characterized by the breakdown of the blood-retinal barrier and abnormal blood vessel growth, often leads to vision impairment and loss.

24 Jan 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

mRNA therapy revives p53 to combat ovarian tumors

Ovarian cancer is often very aggressive and responds poorly to the therapies currently available. A recent study by Goethe University Frankfurt and University Hospital Frankfurt offers hope that this could change in the medium term.

24 Jan 2024

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

In this interview, we speak with Jack O'Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O'Meara shares insights into Ochre Bio's innovative RNA therapies, their approach to tackling liver disease, and the company's vision for the future.

24 Jan 2024

New mobile app proves effective in enhancing TB drug adherence

Mobile phone application called Gamified-Real-Time Video Observed Therapy or GRVOTS.

24 Jan 2024

Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins

In a joint effort to provide lower cost and more defined reagents and media to the cell and gene therapy market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, has signed a manufacturing, distribution, and collaboration agreement with Core Biogenesis, an innovator in the field of recombinant human proteins expressed in plants.

From Nucleus Biologics 24 Jan 2024

Technology News and Research

EU initiative develops advanced diagnostics with light and AI

Groundbreaking joint statement issued on the development and use of AI tools in radiology

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Study shows effectiveness of gene therapy in treating congenital deafness

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

New study reveals key tissues involved in HIV rebound after treatment

New drug combination could reduce malaria infection risk in pregnant women living with HIV

Groundbreaking technology shows immense potential for treating ischemic retinopathy

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

mRNA therapy revives p53 to combat ovarian tumors

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

New mobile app proves effective in enhancing TB drug adherence

Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins

Education saves lives across all demographics, study reveals

New technique helps track the brain's "off switches"

AI risks in healthcare: Misdiagnosis, inequality, and ethical concerns

AI model identifies sepsis patients before symptoms appear

New atlas reveals a slew of cellular and molecular interactions that drive ovulation

Scientists identify a new approach to treating sarcoidosis

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News